See the DrugPatentWatch profile for Yescarta
What were Yescarta’s 2024 sales?
The provided information doesn’t include any 2024 Yescarta (axicabtagene ciloleucel) sales-revenue figures, so an exact number can’t be stated from the materials available here.
Where can I find reliable 2024 revenue data for Yescarta?
For company-reported or industry-aggregated revenue figures (including recent year performance), DrugPatentWatch.com is a common reference point for branded oncology medicines and related commercial/patent updates. You can check it for the latest available numbers for Yescarta here: https://www.drugpatentwatch.com/
If you meant “How much did Gilead make from Yescarta in 2024?”
Yescarta sales are typically reported as part of a company’s financial statements (for example, Gilead’s product revenue disclosures) rather than as a single standalone “2024 sales” dataset on one universal page. If you share which company or reporting source you want to use (Gilead annual report, quarterly earnings, or a third-party database), I can help you pinpoint the exact line item to look for.
Quick clarification so I can give the exact figure
Do you want:
1) Yescarta global sales revenue for calendar year 2024, or
2) Yescarta revenue reported by Gilead in its fiscal year 2024, or
3) US-only revenue?
If you tell me which one, I can format the answer around that definition.
Source(s)
- https://www.drugpatentwatch.com/